The cosmetic market’s boom now includes multiple neuromodulator options to treat a variety of aesthetic concerns, with more options expected within the next year, according to a speaker at South Beach ...
Ocular Therapeutix reported a phase 3 win that it believes can validate its attempts to challenge Regeneron’s entrenched ...
More recently established treatments for RVO have taken a giant leap forward from laser photocoagulation since intravitreally ...
Scientists at Stanford Medicine have discovered a treatment that can reverse cartilage loss in aging joints and even prevent arthritis after knee injuries. By blocking a protein linked to aging, the ...
Comedian Aishwarya Mohanraj has opened up about her dramatic 20 kg weight loss in six months. She revealed that after struggling with PCOD, hypothyroidism and injuries, medically prescribed Mounjaro ...
MILAN ― Ski jumpers and penile injections have become one of the most awkward conversations of the 2026 Winter Games. Now the International Ski and Snowboard Federation has dismissed it all as a "wild ...
Ahead of this week's Opening Ceremony at the Winter Olympics in Milan, the World Anti-Doping Agency has addressed claims originating from a German tabloid that male skiers could be injecting ...
Though lab-made peptides are touted as a cure-all, they are not FDA-regulated and pose serious risks, experts warn Here’s a new trend that sounds unwise: buying unregulated substances from dealers in ...
The Nawaloka College of Higher Studies (NCHS) once again partnered EDEX Expo as the Platinum Partner, marking a strong presence at both the Colombo and Kandy editions of Sri Lanka’s largest education ...
As a model of successful aging, you can’t beat 82-year-old Juan López García. Really, you can’t beat him. Subscribe to The Post Most newsletter for the most important and interesting stories from The ...
The Nawaloka College of Higher Studies (NCHS) was the Platinum Partner at EDEX Expo, marking a strong presence at both the Colombo and Kandy editions of the largest education and careers exhibition.
Pfizer said its experimental obesity drug, which it acquired through Metsera, drove solid weight loss when taken once a month in a mid-stage trial. The data offer early evidence that the injection can ...